Point-of-Care Glucose Testing Market Projected To Raise At USD 4.51 Billion By 2030

San Francisco, 6 July 2023: The Report Point-of-Care Glucose Testing Market Size, Share & Trends Analysis Report By Product (Accu Check Aviva Meter, Onetouch Verio Flex, i-STAT), By Region, And Segment Forecasts, 2023 - 2030

The global point-of-care glucose testing market size is expected to reach USD 4.51 billion by 2030, registering a CAGR of 4.1% over the forecast period, according to a new report by Grand View Research, Inc. An increase in the demand for Point-of-Care Testing (POCT) has been witnessed in recent years. As compared to the conventional laboratory testing performed in central lab settings, glucose POCT aids in performing effective diagnosis at the patient’s bedside. The easy and convenient operation of POCT has largely favored the growing usage of glucose meters across medical settings. The demand for performing bedside monitoring of blood sugar levels efficiently in a capillary blood sample and the need to ensure better management of carbohydrate metabolism have propelled the companies to launch innovative glucose meters in the market.

Various companies are investing in the development of needle-less devices to offer painless management of diabetes. For instance, GlucoTrack, a product manufactured by Integrity Applications (Israel), performs quantification using electromagnetic, ultrasonic, and thermal waves in combination. Eversense, painless glucose monitoring subcutaneous implant by Senseonics, quantifies glucose levels in interstitial fluid when placed beneath the skin. This is followed by data transmission to show the results in real-time. The latest no-code monitoring systems help in minimizing the errors that occur due to incorrect entry of strip codes. Whereas, others are incorporating noble metals, such as silver, gold, and platinum, which effectively reduce the electrical noise further improving accuracy.

Access Research Report of Point-of-Care Glucose Testing Market @ https://www.grandviewresearch.com/industry-analysis/point-of-care-glucose-testing-market

Point-of-Care Glucose Testing Market Report Highlights

• Accu-Chek Inform II accounted for the second-largest share in 2022 and is anticipated to maintain this trend throughout the forecast period
• Bayer Contour blood glucose monitoring system is set to grow at a CAGR of 6.1% from 2023 to 2030
• North America is the leading regional market due to the higher penetration of novel diagnostic techniques
• Asia Pacific is estimated to register the fastest CAGR owing to the ever-increasing prevalence of diabetes and numerous untapped growth opportunities in diagnostics
• Moreover, a robust network of local manufacturers has significantly contributed to the revenue generated in this region

Point-of-Care Glucose Testing Market Report Scope

Report Attribute	Details
Market size value in 2023	USD 3.40 billion
Revenue forecast in 2030	USD 4.51 billion
Growth rate	CAGR of 4.1% from 2023 to 2030
Base year for estimation	2022
Historical data	2016 - 2021
Forecast period	2023 - 2030

List of Key Players in the Point-of-Care Glucose Testing Market

• Hoffmann-La Roche Ltd.
• Abbott
• Nipro
• PlatInium Equity Advisors, LLC (Lifescan, Inc.)
• Nova Biomedical
• ACON Laboratories
• Trividia Health, Inc.
• Prodigy Diabetes Care, LLC
• Bayer AG/Ascensia Diabetes Care Holdings AG
• EKF Diagnostics

Access Press Release of Point-of-Care Glucose Testing Market @ https://www.grandviewresearch.com/press-release/global-point-of-care-glucose-testing-market